Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths
worldwide and is increasing in incidence. Local ablative therapy plays a leading role in HCC …

Peptide‐based hydrogel biomaterials have emerged as an excellent strategy for immune
system modulation. Peptide‐based hydrogels are supramolecular materials that self …

Peptide vaccines have shown great potential in cancer immunotherapy by targeting tumor
antigens and activating the patient's immune system to mount a specific response against …

XPO1 (Exportin-1/CRM1) is a nuclear export protein that is frequently overexpressed in
cancer and functions as a driver of oncogenesis. Currently small molecules that target XPO1 …

NK cells are promising cellular therapeutics against hematological and solid malignancies.
Immunogenetic studies have identified that various activating killer cell Ig-like receptors …

Simple Summary Immunotherapies are promising approaches to curing different acute
leukemias. Natural killer (NK) cells are lymphocytes that are efficient in the elimination of …

Natural killer (NK) cells and type 1 innate lymphoid cells (ILC1) are specific innate lymphoid
cell subsets that are key for the detection and elimination of pathogens and cancer cells. In …

Immunotherapy for allergy has been practiced for over 100 years. Low-dose repeated
exposure to specific allergen extracts over several months to years can successfully induce …

The fact that genetic and environmental factors could trigger disruption of the epithelial
barrier and subsequently initiate a Th2 inflammatory cascade conversely proposes that …

Peptides exhibit various biological activities, including biorecognition, cell targeting, and
tumor penetration, and can stimulate immune cells to elicit immune responses for tumor …